These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16563994)

  • 21. 3D localization of implanted radioactive sources in the prostate using trans-urethral ultrasound.
    Holmes DR; Davis BJ; Robb RA
    Stud Health Technol Inform; 2001; 81():199-205. PubMed ID: 11317739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of selection of post-implant technique on dosimetry parameters for permanent prostate implants.
    Haworth A; Ebert M; St Clair S; Carey BM; Flynn A; Bottomley DM; Duchesne GM; Joseph D; Ash D
    Brachytherapy; 2005; 4(2):146-53. PubMed ID: 15893269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidity.
    Allen ZA; Merrick GS; Butler WM; Wallner KE; Kurko B; Anderson RL; Murray BC; Galbreath RW
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):981-7. PubMed ID: 15989998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conformal prostate brachytherapy: initial experience of a phase I/II dose-escalating trial.
    Martinez A; Gonzalez J; Stromberg J; Edmundson G; Plunkett M; Gustafson G; Brown D; Yan D; Vicini F; Brabbins D
    Int J Radiat Oncol Biol Phys; 1995 Dec; 33(5):1019-27. PubMed ID: 7493828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward a dynamic real-time intraoperative permanent prostate brachytherapy methodology.
    Potters L; Calguaru E; Thornton KB; Jackson T; Huang D
    Brachytherapy; 2003; 2(3):172-80. PubMed ID: 15062140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of urinary catheterization on dosimetry after prostate implant brachytherapy with palladium-103 or iodine-125.
    Shirvani SM; Kudchadker RJ; Bruno TL; Likhacheva A; Swanson DA; Frank SJ
    Brachytherapy; 2011; 10(4):269-74. PubMed ID: 21296031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Importance of the CT/MRI fusion method as a learning tool for CT-based postimplant dosimetry in prostate brachytherapy.
    Tanaka O; Hayashi S; Sakurai K; Matsuo M; Nakano M; Maeda S; Hoshi H; Deguchi T
    Radiother Oncol; 2006 Dec; 81(3):303-8. PubMed ID: 17125859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen deprivation-induced changes in prostate anatomy predict urinary morbidity after permanent interstitial brachytherapy.
    Hinerman-Mulroy A; Merrick GS; Butler WM; Wallner KE; Allen Z; Adamovich E
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1367-82. PubMed ID: 15275722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Centralized multiinstitutional postimplant analysis for interstitial prostate brachytherapy.
    Bice WS; Prestidge BR; Grimm PD; Friedland JL; Feygelman V; Roach M; Prete JJ; Dubois DF; Blasko JC
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):921-7. PubMed ID: 9652858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of MRI-based and CT/MRI fusion-based postimplant dosimetric analysis of prostate brachytherapy.
    Tanaka O; Hayashi S; Matsuo M; Sakurai K; Nakano M; Maeda S; Kajita K; Deguchi T; Hoshi H
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):597-602. PubMed ID: 16966002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of timing on the dosimetric analysis of transperineal ultrasound-guided, prostatic conformal brachytherapy.
    Merrick GS; Butler WM; Dorsey AT; Walbert HL
    Radiat Oncol Investig; 1998; 6(4):182-90. PubMed ID: 9727878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Source localization following permanent transperineal prostate interstitial brachytherapy using magnetic resonance imaging.
    Dubois DF; Prestidge BR; Hotchkiss LA; Bice WS; Prete JJ
    Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1037-41. PubMed ID: 9392542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosimetric consequences of using a surrogate urethra to estimate urethral dose after brachytherapy for prostate cancer.
    Lee HK; D'Souza WD; Yamal JM; Pollack A; Lee AK; Palmer MB; Kuban DA
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):355-61. PubMed ID: 12957245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry.
    Su Y; Davis BJ; Furutani KM; Herman MG; Robb RA
    Phys Med Biol; 2007 Jun; 52(11):3105-19. PubMed ID: 17505092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there a role for postimplant dosimetry after real-time dynamic permanent prostate brachytherapy?
    Potters L; Calugaru E; Jassal A; Presser J
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1014-9. PubMed ID: 16682144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of 3 different postimplant dosimetry methods following permanent 125I prostate seed brachytherapy.
    Marcu LG; Gowda R
    Med Dosim; 2013; 38(3):309-14. PubMed ID: 23611630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation.
    Merrick GS; Butler WM; Dorsey AT; Lief JH
    Tech Urol; 2001 Sep; 7(3):233-40. PubMed ID: 11575521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of interobserver variability on transrectal ultrasonography-based postimplant dosimetry.
    Xue J; Waterman F; Handler J; Gressen E
    Brachytherapy; 2006; 5(3):174-82. PubMed ID: 16864069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosimetric comparison of interactive planned and dynamic dose calculated prostate seed brachytherapy.
    Meijer GJ; van den Berg HA; Hurkmans CW; Stijns PE; Weterings JH
    Radiother Oncol; 2006 Sep; 80(3):378-84. PubMed ID: 16930753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Foley catheters on seed positions and urethral dose in (125)I and (103)Pd prostate implants.
    Brezovich IA; Pareek PN; Duan J; Fiveash J
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1461-8. PubMed ID: 11286854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.